MetaVia (MTVA) Stock

Profile

Full Name:

MetaVia Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

05 August 2016

Indexes:

Not included

Description:

MetaVia Inc. is a technology company focused on developing innovative solutions for data management and analytics, helping businesses optimize their operations and make informed decisions.

Events Calendar

Earnings

Next earnings date:

May 09, 2025

Recent quarterly earnings:

Nov 07, 2024

Recent annual earnings:

Apr 15, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

30 Dec '24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference
MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference
MetaVia to Hold Advisory Committee Meeting at the 9th Annual MASH-TAG 2025 Conference
MTVA
prnewswire.com10 January 2025

CAMBRIDGE, Mass. , Jan. 10, 2025 /PRNewswire/ -- MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it is holding an Advisory Committee meeting today, at the 9th Annual MASH-TAG 2025 Conference, to discuss the previously announced positive top-line 16-week results from the two-part Phase 2a clinical trial of DA-1241, a novel G-Protein-Coupled Receptor 119 (GPR119) agonist, in patients with presumed metabolic dysfunction-associated steatohepatitis (MASH).

FAQ

  • What is the primary business of MetaVia?
  • What is the ticker symbol for MetaVia?
  • Does MetaVia pay dividends?
  • What sector is MetaVia in?
  • What industry is MetaVia in?
  • What country is MetaVia based in?
  • When did MetaVia go public?
  • Is MetaVia in the S&P 500?
  • Is MetaVia in the NASDAQ 100?
  • Is MetaVia in the Dow Jones?
  • When was MetaVia's last earnings report?
  • When does MetaVia report earnings?
  • Should I buy MetaVia stock now?

What is the primary business of MetaVia?

MetaVia Inc. is a technology company focused on developing innovative solutions for data management and analytics, helping businesses optimize their operations and make informed decisions.

What is the ticker symbol for MetaVia?

The ticker symbol for MetaVia is NASDAQ:MTVA

Does MetaVia pay dividends?

No, MetaVia does not pay dividends

What sector is MetaVia in?

MetaVia is in the Healthcare sector

What industry is MetaVia in?

MetaVia is in the Biotechnology industry

What country is MetaVia based in?

MetaVia is headquartered in United States

When did MetaVia go public?

MetaVia's initial public offering (IPO) was on 05 August 2016

Is MetaVia in the S&P 500?

No, MetaVia is not included in the S&P 500 index

Is MetaVia in the NASDAQ 100?

No, MetaVia is not included in the NASDAQ 100 index

Is MetaVia in the Dow Jones?

No, MetaVia is not included in the Dow Jones index

When was MetaVia's last earnings report?

MetaVia's most recent earnings report was on 7 November 2024

When does MetaVia report earnings?

The next expected earnings date for MetaVia is 9 May 2025

Should I buy MetaVia stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions